# Elpen Pharmaceutical Co. Inc. clinical trials: 45 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 45 trials with Elpen Pharmaceutical Co. Inc. as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Elpen Pharmaceutical Co. Inc.: 45 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/elpen-pharmaceutical-co-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 45
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 45, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 20, 2026 | NCT07352878 | Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece. | Elpen Pharmaceutical Co. Inc. | Observational | Not yet recruiting | Thalassemia, Iron Overload | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07352878) |
| April 29, 2025 | NCT06949956 | Administration of Fingolimod in Greek Patients With Multiple Sclerosis. | Elpen Pharmaceutical Co. Inc. | Observational | Not yet recruiting | Relapsing Remitting Multiple Sclerosis | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06949956) |
| July 30, 2024 | NCT06528613 | Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin. | Elpen Pharmaceutical Co. Inc. | Observational | Recruiting | Benign Prostatic Hyperplasia | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06528613) |
| May 3, 2024 | NCT06399341 | Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR). | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Papillomavirus Infections | 524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06399341) |
| December 14, 2023 | NCT06170125 | QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. | Elpen Pharmaceutical Co. Inc. | Observational | Unknown | COPD | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06170125) |
| November 7, 2023 | NCT06117722 | TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. | Elpen Pharmaceutical Co. Inc. | Observational | Unknown | Chronic Heart Failure | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06117722) |
| July 14, 2022 | NCT05459194 | Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler | Elpen Pharmaceutical Co. Inc. | Not applicable | Completed | Asthma | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05459194) |
| June 22, 2022 | NCT05426915 | Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice. | Elpen Pharmaceutical Co. Inc. | Observational | Unknown | Copd, COPD Exacerbation | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05426915) |
| December 23, 2021 | NCT05168215 | Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. | Elpen Pharmaceutical Co. Inc. | Observational | Unknown | Scleroderma, Digital Ulcer, Autoimmune Diseases, Diffuse Cutaneous Systemic Sclerosis, Reynold Syndrome | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05168215) |
| April 8, 2021 | NCT04835961 | AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Asthma | 1,037 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04835961) |
| April 5, 2021 | NCT04831476 | Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Benign Prostatic Hyperplasia | 1,296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04831476) |
| May 13, 2019 | NCT03947866 | Ezetimibe-Rosuvastatin Evaluation Study | Elpen Pharmaceutical Co. Inc. | Observational | Unknown | Hypercholesterolemia, Hyperlipidemias, Combinations of Drugs; Dependence | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03947866) |
| May 13, 2019 | NCT03947853 | Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse... | Elpen Pharmaceutical Co. Inc. | Observational | Withdrawn | Heart Failure, Heart Failure NYHA Class III, Heart Failure NYHA Class II, Heart Failure NYHA Class IV | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03947853) |
| March 13, 2019 | NCT03873584 | Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy | Elpen Pharmaceutical Co. Inc. | Observational | Withdrawn | Anemia, Iron-deficiency, Iron Deficiency Anemia, Fatigue | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03873584) |
| March 13, 2019 | NCT03873571 | Adherence of Iron Succinylate Therapy in Pregnancy | Elpen Pharmaceutical Co. Inc. | Observational | Withdrawn | Pregnancy Related, Pregnancy Anemia, Iron Deficiency Anemia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03873571) |
| February 28, 2019 | NCT03858348 | A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD )... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | COPD, COPD Exacerbation | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03858348) |
| November 6, 2017 | NCT03329729 | PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Dyslipidemias, Hyperlipidemias, Risk Factor, Cardiovascular, Quality of Life | 4,700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03329729) |
| October 23, 2017 | NCT03317262 | Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Depression, Anxiety Disorders | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03317262) |
| October 3, 2017 | NCT03300076 | COMPLliancE and qualiTy of lifE in Asthma | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Asthma, Compliance, Patient, Quality of Life | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03300076) |
| October 3, 2017 | NCT03299673 | AdHerencE to Treatment and quAlity of Life in COPD | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Chronic Obstructive Pulmonary Disease, Compliance, Patient, Quality of Life | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03299673) |
| May 22, 2017 | NCT03162120 | Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation... | Elpen Pharmaceutical Co. Inc. | Phase 2/3 | Withdrawn | Atrial Fibrillation, Recurrence | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03162120) |
| May 3, 2017 | NCT03139084 | Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension | Elpen Pharmaceutical Co. Inc. | Observational | Withdrawn | Pulmonary Hypertension | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03139084) |
| February 16, 2017 | NCT03055793 | Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Asthma, Quality of Life, Satisfaction | 1,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03055793) |
| January 27, 2017 | NCT03033758 | Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Asthma, Quality of Life | 980 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03033758) |
| December 1, 2016 | NCT02978703 | EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in... | Elpen Pharmaceutical Co. Inc. | Observational | Completed | Chronic Obstructive Pulmonary Disease | 1,730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02978703) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2/3 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 40 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 30 |
| Withdrawn | 7 |
| Unknown | 5 |
| Not yet recruiting | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Asthma | 9 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Atrial Fibrillation | 3 |
| Heart Failure | 3 |
| Hypercholesterolemia | 3 |
| Hypertension | 2 |
| Cardiovascular Diseases | 2 |
| Patient Compliance | 2 |
| digital ulcers | 2 |
| Scleroderma, Diffuse | 2 |
| Prostatic Hyperplasia | 2 |
| Dyslipidemias | 2 |
| Hyperlipidemias | 2 |
| Anemia, Iron-Deficiency | 2 |
| Alzheimer Disease | 1 |
| Dementia | 1 |
| Cognitive Dysfunction | 1 |
| Recurrence | 1 |
| Arrhythmias, Cardiac | 1 |
| Diabetes Mellitus | 1 |
| Renal Insufficiency | 1 |
| Sleep Apnea Syndromes | 1 |
| Papillomavirus Infections | 1 |
| Angina, Unstable | 1 |
| Depression | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Home builders in the United States](https://specstream.ai/data/businesses/home-builders/united-states)
- [Pressure washing companies in the United States](https://specstream.ai/data/businesses/pressure-washing-companies/united-states)
- [Aircraft manufacturers in the United States](https://specstream.ai/data/businesses/aircraft-manufacturers/united-states)
- [Drywall contractors in the United States](https://specstream.ai/data/businesses/drywall-contractors/united-states)
- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
